Biocept Financials
| BIOCQ Stock | 0.0001 0.0001 50.00% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.51 | 2.67 |
|
|
Investors should never underestimate Biocept's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Biocept's cash flow, debt, and profitability to make informed and accurate decisions about investing in Biocept.
Net Income |
|
Biocept | Select Account or Indicator | Build AI portfolio with Biocept Stock |
Understanding current and past Biocept Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biocept's financial statements are interrelated, with each one affecting the others. For example, an increase in Biocept's assets may result in an increase in income on the income statement.
Biocept Stock Summary
Biocept is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US09072V6002 |
| Business Address | 9955 Mesa Rim |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | biocept.com |
| Phone | 858 320 8200 |
Biocept Key Financial Ratios
| Return On Equity | -1.87 | ||||
| Operating Margin | (10.38) % | ||||
| Price To Sales | 0.0004 X | ||||
| Revenue | 25.86 M | ||||
| Gross Profit | (14.3 M) |
Biocept Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biocept's current stock value. Our valuation model uses many indicators to compare Biocept value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biocept competition to find correlations between indicators driving Biocept's intrinsic value. More Info.Biocept is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . At this time, Biocept's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Biocept by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Biocept Systematic Risk
Biocept's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biocept volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on Biocept correlated with the market. If Beta is less than 0 Biocept generally moves in the opposite direction as compared to the market. If Biocept Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Biocept is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biocept is generally in the same direction as the market. If Beta > 1 Biocept moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Biocept Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Biocept's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Biocept growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Biocept December 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biocept help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biocept. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biocept based on widely used predictive technical indicators. In general, we focus on analyzing Biocept Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biocept's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1227 | |||
| Maximum Drawdown | 1995.0 |
Additional Tools for Biocept Stock Analysis
When running Biocept's price analysis, check to measure Biocept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocept is operating at the current time. Most of Biocept's value examination focuses on studying past and present price action to predict the probability of Biocept's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocept's price. Additionally, you may evaluate how the addition of Biocept to your portfolios can decrease your overall portfolio volatility.